Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
The firm will evaluate its epigenomic liquid biopsy test to detect pancreatic cancer among patients considered high-risk for the disease due to their diabetes.
Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform
BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.
Epigenomics Expecting Lower Loss in 2022 as It Launches Liquid Biopsy Study
The company said that it has begun enrollment in a prospective clinical trial of its next-generation blood-based test for colorectal cancer.
BriaCell, Caris Life Sciences Partner to Bolster New Immunotherapy Development
The immunotherapy firm will use Caris' "Right-In-Time" clinical trial network to recruit eligible patients for a trial of its cell-based treatment, Bria-IMT.
Beckman Coulter Partners With Mass General to Evaluate Pediatric Infection Dx
Using funding from BARDA, the partners will examine whether Beckman's monocyte distribution width assay can predict early sepsis in children.